Nhale boosts acquisition efforts in medical marijuana market

PURSUING a larger share of the booming medical marijuana market, Nhale Inc. (OTCQB: NHLE) is boosting its acquisition efforts with the execution of a term sheet for $10 million in debt financing with Toronto-based private investment group Four Twenty Investments Inc. 

 

U.S.-based Nhale will use the proceeds of the financing to complete its planned acquisitions of revenue generating medical and recreational marijuana operations in states that have legalized the use of cannabis for medical purposes. The company has been actively pursuing firms with proven business models positioned to make a significant impact within the medical and recreational cannabis market.  

 

The enactment of laws allowing the growing and distribution of cannabis for medical use is spurring the medical marijuana sector. Demand has also been rising on the back of trends favoring the legitimizing of alternative medical treatments.

 

The medical cannabis market in the U.S. is expected to top $2.3 billion this year. It will exceed $10 billion by 2018, according to ArcView.

 

Nhale president and CEO Lance Williams said, "As a highly regulated industry where licenses are constantly on the line, brands must establish strong protocols and skills. Nhale is poised to leverage its talent, resources, and leadership to become a premier mover in the industry. With a growth rate of 38% since 2011, the medical marijuana market offers enormous opportunities for our highly experienced team to successfully collaborate with the sector's most robust start-ups."

 

Four Twenty Investments offers financing and strategic investments of medical marijuana and similar companies involved in the cannabis industry.